Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).

Pérez de Isla L, Alonso R, Mata N, Fernández-Pérez C, Muñiz O, Díaz-Díaz JL, Saltijeral A, Fuentes-Jiménez F, de Andrés R, Zambón D, Piedecausa M, Cepeda JM, Mauri M, Galiana J, Brea Á, Sanchez Muñoz-Torrero JF, Padró T, Argueso R, Miramontes-González JP, Badimón L, Santos RD, Watts GF, Mata P.

Circulation. 2017 May 30;135(22):2133-2144. doi: 10.1161/CIRCULATIONAHA.116.024541. Epub 2017 Mar 8.

PMID:
28275165
2.

Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).

Pérez de Isla L, Alonso R, Mata N, Saltijeral A, Muñiz O, Rubio-Marin P, Diaz-Diaz JL, Fuentes F, de Andrés R, Zambón D, Galiana J, Piedecausa M, Aguado R, Mosquera D, Vidal JI, Ruiz E, Manjón L, Mauri M, Padró T, Miramontes JP, Mata P; SAFEHEART Investigators.

Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):2004-10. doi: 10.1161/ATVBAHA.116.307514. Epub 2016 Jul 21.

PMID:
27444203
3.

Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.

Perez de Isla L, Alonso R, Watts GF, Mata N, Saltijeral Cerezo A, Muñiz O, Fuentes F, Diaz-Diaz JL, de Andrés R, Zambón D, Rubio-Marin P, Barba-Romero MA, Saenz P, Sanchez Muñoz-Torrero JF, Martinez-Faedo C, Miramontes-Gonzalez JP, Badimón L, Mata P; SAFEHEART Investigators.

J Am Coll Cardiol. 2016 Mar 22;67(11):1278-85. doi: 10.1016/j.jacc.2016.01.008.

4.

Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study.

Fuentes F, Alcala-Diaz JF, Watts GF, Alonso R, Muñiz O, Díaz-Díaz JL, Mata N, Sanchez Muñoz-Torrero JF, Brea Á, Galiana J, Figueras R, Aguado R, Piedecausa M, Cepeda JM, Vidal JI, Rodríguez-Cantalejo F, López-Miranda J, Mata P; SAFEHEART Investigators.

Int J Cardiol. 2015 Dec 15;201:79-84. doi: 10.1016/j.ijcard.2015.07.107. Epub 2015 Aug 5.

PMID:
26296047
5.

Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation.

Alonso R, Andres E, Mata N, Fuentes-Jiménez F, Badimón L, López-Miranda J, Padró T, Muñiz O, Díaz-Díaz JL, Mauri M, Ordovás JM, Mata P; SAFEHEART Investigators.

J Am Coll Cardiol. 2014 May 20;63(19):1982-9. doi: 10.1016/j.jacc.2014.01.063. Epub 2014 Mar 13.

6.

[Clinical profile of patients with very high hypertriglyceridemia from the Registry of Hypertriglyceridemia of the Spanish Atherosclerosis Society].

Pedragosa A, Merino J, Aranda JL, Galiana J, Godoy D, Panisello JM, Ascaso JF, Civeira F, Masana L, Pedro-Botet J; Registro de HTG de la SEA.

Clin Investig Arterioscler. 2013 Jan-Mar;25(1):8-15. doi: 10.1016/j.arteri.2012.11.001. Epub 2012 Dec 21. Spanish.

PMID:
23522276
7.

New cyclometallated precursors of unsubstituted N-phenylpyrazole [{Pd(phpz)(μ-X)}2] (X = AcO or OH) and study of their reactivity towards selected ligands.

Serrano JL, García L, Pérez J, Pérez E, Galiana JM, García J, Martínez M, Sánchez G, da Silva I.

Dalton Trans. 2011 Jan 7;40(1):156-68. doi: 10.1039/c0dt00814a. Epub 2010 Nov 9.

PMID:
21060953
8.

Orthogonal non-covalent binding forces in solid state supramolecular herringbone-shaped "interlocked dimers". Pseudopolymorphism in [(ppy)Pd(mu-pz)](2) (ppy = 2-(2-pyridyl)phenyl, pz = pyrazol-1-yl) complex.

Pérez J, Espinosa A, Galiana JM, Pérez E, Serrano JL, Aranda MA, Insausti M.

Dalton Trans. 2009 Nov 21;(43):9625-36. doi: 10.1039/b910502f. Epub 2009 Sep 23.

PMID:
19859618
9.

Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors.

Alonso R, Mata N, Castillo S, Fuentes F, Saenz P, Muñiz O, Galiana J, Figueras R, Diaz JL, Gomez-Enterría P, Mauri M, Piedecausa M, Irigoyen L, Aguado R, Mata P; Spanish Familial Hypercholesterolaemia Group.

Atherosclerosis. 2008 Oct;200(2):315-21. doi: 10.1016/j.atherosclerosis.2007.12.024. Epub 2008 Feb 20.

PMID:
18243212
10.

Structure determination of di-mu-hydroxo-bis[(2-(2-pyridyl)phenyl-kappa2N,C1)palladium(II)] by X-ray powder diffractometry.

Pérez J, Serrano JL, Galiana JM, Cumbrera FL, Ortiz AL, Sánchez G, García J.

Acta Crystallogr B. 2007 Feb;63(Pt 1):75-80. Epub 2007 Jan 15.

PMID:
17235197
11.

[Bronchiolitis obliterans organizing pneumonia. Review of six cases].

Garay JB, Zurdo MR, López OA, Gaviria AZ, Medina LV, Delgado EG, Entrecanales MV, Galiana JR.

Rev Clin Esp. 1996 Feb;196(2):103-6. Spanish.

PMID:
8685481
12.

[Toxic myopathies related to the administration of hypolipidemic agents: are the drugs the only things responsible?].

Galiana J, Marchán E, Montés I, Pato S.

Rev Clin Esp. 1995 Sep;195(9):620-2. Review. Spanish.

PMID:
7481005
13.

Decreased isotretinoin efficacy during acute alcohol intake.

Soria C, Allegue F, Galiana J, Ledo A.

Dermatologica. 1991;182(3):203. No abstract available.

PMID:
1831775
14.

[Psychopharmacology of pain].

Gilbert-Rahola J, Galiana J, Micó JA.

Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1985 Nov-Dec;13(6):358-60. Spanish. No abstract available.

PMID:
3834780
15.

Osteoarticular manifestations of exposure to toxic rapeseed oil.

Gordo JM, Díaz de Rojas F, Borda IA, Galiana JR, Posada de la Paz M, Castro García M, Alvarez-Arenas RP, Tabuenca Oliver JM.

Arthritis Rheum. 1983 Sep;26(9):1175-6. No abstract available.

PMID:
6615575
16.

[Effect of neurohypophyseal hormones on the maze learning of rats].

Galiana J, López A, Lorenzo JR, Gil M, Hidalgo JJ, Gibert-Rahola J, Cuenca E.

Arch Farmacol Toxicol. 1982 Dec;8(3):189-92. Spanish. No abstract available.

PMID:
7183250
17.

[Prolactin in depression].

Cuenca E, Galiana J, Cañete JM.

Arch Farmacol Toxicol. 1978 Apr;4(1):47-9. Spanish. No abstract available.

PMID:
697402
18.

[TRH and lipid metabolism].

Cuenca E, Galiana J, Lafuente L, Alamo C, López A.

Arch Farmacol Toxicol. 1978 Apr;4(1):21-4. Spanish. No abstract available.

PMID:
100061
19.

[Interaction between clorgyline and reserpine on the arterial blood pressure on the spinal cat (author's transl)].

Galiana J, Alamo C, Cuenca E.

Arch Farmacol Toxicol. 1977 Aug;3(2):109-16. Spanish. No abstract available.

PMID:
921331
20.

Enhancement of noradrenaline responses by thyrotropine-releasing hormone.

Cuenca E, Serrano MI, Gibert-Rahola J, Galiana J.

J Pharm Pharmacol. 1975 Mar;27(3):199-200. No abstract available.

PMID:
238005

Supplemental Content

Loading ...
Support Center